RxSight, Inc. (RXST) Earnings
|
Expand Research on RXST
| Next EPS Date | 8/10/26 | EPS Growth Rate | -24.1% |
|---|---|---|---|
| Average EPS % Beat Rate | +41.7% | Revenue Growth Rate | -4.5% |
| Average % Move 1-Wk after EPS | -0.7% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/10/26  |
Q226 | N/A | -$0.36 | N/A | N/A | $32.08M | N/A | N/A | N/A | ||
| 5/6/26 | Q126 | -$0.19 | -$0.31 | +$0.12 | $30.9M | $29.75M | N/A |  | | Details | |
| 2/25/26 | Q425 | -$0.03 | -$0.35 | +$0.32 | $32.6M | $28.11M | N/A | | | Details | |
| 11/5/25 | Q325 | -$0.04 | -$0.38 | +$0.34 | $30.3M | $25.28M | = | | | Details | |
| 8/7/25 | Q225 | -$0.29 | -$0.19 | -$0.10 | $33.6M | $38.55M | = | | | Details | |
| 5/7/25 | Q125 | -$0.03 | -$0.20 | +$0.17 | $37.9M | $39.09M | = | | | Details | |
| 2/25/25 | Q424 | $0.03 | -$0.17 | +$0.20 | $40.2M | $40.39M | = | | | Details | |
| 11/7/24 | Q324 | $0.00 | -$0.25 | +$0.25 | $35.3M | $35.06M | = | | | Details |
